• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全民医疗保健系统下药物洗脱支架植入的酌情决策与差异:一项基于人群的研究。

Discretionary decisions and disparities in receiving drug-eluting stents under a universal healthcare system: A population-based study.

作者信息

Kuo Raymond N, Lai Chao-Lun, Yeh Yi-Chun, Lai Mei-Shu

机构信息

Institute of Health Policy and Management, College of Public Health, National Taiwan University, Taipei City, Taiwan.

Division of Cardiology, National Taiwan University Hospital Hsin-Chu Branch, Hsin-Chu City, Taiwan.

出版信息

PLoS One. 2017 Jun 8;12(6):e0179127. doi: 10.1371/journal.pone.0179127. eCollection 2017.

DOI:10.1371/journal.pone.0179127
PMID:28594876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5464647/
Abstract

OBJECTIVES

One of the main objectives behind the expansion of insurance coverage is to eliminate disparities in health and healthcare. However, researchers have not yet fully elucidated the reasons for disparities in the use of high-cost treatments among patients of different occupations. Furthermore, it remains unknown whether discretionary decisions made at the hospital level have an impact on the administration of high-cost interventions in a universal healthcare system. This study investigated the adoption of drug-eluting stents (DES) versus bare metal-stents (BMS) among patients in different occupations and income levels, with the aim of gauging the degree to which the inclination of health providers toward treatment options could affect treatment choices at the patient-level within a universal healthcare system.

DESIGN AND PARTICIPANTS

We adopted a cross-sectional observational study design using hierarchical modeling in conjunction with the population-based National Health Insurance database of Taiwan. Patients who received either a BMS or a DES between 2007 and 2010 were included in the study.

RESULTS

During the period of study, 42,124 patients received a BMS (65.3%) and 22,376 received DES (34.7%). Patients who were physicians or the family members of physicians were far more likely to receive DES (OR: 3.18, CI: 2.38-4.23) than were patients who were neither physicians nor in other high-status jobs (employers, other medical professions, or public service). Similarly, patients in the top 5% income bracket had a higher probability of receiving a DES (OR: 2.23, CI: 2.06-2.47, p < .001), than were patients in the lowest income bracket. After controlling for patient-level factors, the inclination of hospitals (proportion of DES>50% or between 25% and 50%) was shown to be strongly associated with the selection of DESs (OR: 3.64 CI: 3.24-4.09 and OR: 2.16, CI: 2.01-2.33, respectively).

CONCLUSIONS

Even under the universal healthcare system in Taiwan, socioeconomic disparities in the use of high-cost services remain widespread. Differences in the care received by patients of lower socioeconomic status may be due to the discretionary decisions of healthcare providers.

摘要

目的

扩大保险覆盖范围背后的主要目标之一是消除健康和医疗保健方面的差距。然而,研究人员尚未充分阐明不同职业患者在使用高成本治疗方法上存在差异的原因。此外,在全民医疗保健系统中,医院层面的自主决策是否会对高成本干预措施的管理产生影响仍不清楚。本研究调查了不同职业和收入水平的患者中药物洗脱支架(DES)与裸金属支架(BMS)的使用情况,旨在衡量在全民医疗保健系统中,医疗服务提供者对治疗方案的倾向在多大程度上会影响患者层面的治疗选择。

设计与参与者

我们采用横断面观察性研究设计,结合基于人群的台湾国民健康保险数据库进行分层建模。研究纳入了2007年至2010年间接受BMS或DES治疗的患者。

结果

在研究期间,42124名患者接受了BMS(65.3%),22376名患者接受了DES(34.7%)。医生或医生家属比既不是医生也不在其他高地位职业(雇主、其他医疗职业或公共服务)的患者更有可能接受DES(比值比:3.18,可信区间:2.38 - 4.23)。同样,收入最高的5%人群比收入最低的人群接受DES的概率更高(比值比:2.23,可信区间:2.06 - 2.47,p <.001)。在控制了患者层面的因素后,医院的倾向(DES比例>50%或在25%至50%之间)与DES的选择密切相关(比值比分别为:3.64,可信区间:3.24 - 4.09;以及比值比:2.16,可信区间:2.01 - 2.33)。

结论

即使在台湾的全民医疗保健系统下,高成本服务使用方面的社会经济差距仍然普遍存在。社会经济地位较低的患者所接受的护理差异可能归因于医疗服务提供者的自主决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fdd/5464647/9da19e22b27b/pone.0179127.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fdd/5464647/b19262d2e115/pone.0179127.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fdd/5464647/9da19e22b27b/pone.0179127.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fdd/5464647/b19262d2e115/pone.0179127.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fdd/5464647/9da19e22b27b/pone.0179127.g002.jpg

相似文献

1
Discretionary decisions and disparities in receiving drug-eluting stents under a universal healthcare system: A population-based study.全民医疗保健系统下药物洗脱支架植入的酌情决策与差异:一项基于人群的研究。
PLoS One. 2017 Jun 8;12(6):e0179127. doi: 10.1371/journal.pone.0179127. eCollection 2017.
2
Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials.比较新一代药物洗脱支架和裸金属支架在急性 ST 段抬高型心肌梗死患者中的应用:EXAMINATION(急性心肌梗死中评价 Xience-V 支架的临床研究)和 COMFORTABLE-AMI(急性 ST 段抬高型心肌梗死中生物可降解涂层雷帕霉素洗脱支架与裸金属支架的比较研究)试验的汇总分析。
JACC Cardiovasc Interv. 2014 Jan;7(1):55-63. doi: 10.1016/j.jcin.2013.07.012. Epub 2013 Dec 11.
3
The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.血管成像在常规经皮冠状动脉介入治疗中的作用:金属裸支架和药物洗脱支架试验的荟萃分析。
Cardiovasc Ther. 2015 Dec;33(6):360-6. doi: 10.1111/1755-5922.12160.
4
Safety and effectiveness of drug-eluting versus bare-metal stents in saphenous vein bypass graft percutaneous coronary interventions: insights from the Veterans Affairs CART program.药物洗脱支架与金属裸支架在隐静脉旁路移植经皮冠状动脉介入治疗中的安全性和有效性:来自退伍军人事务 CART 计划的见解。
J Am Coll Cardiol. 2014 Oct 28;64(17):1825-36. doi: 10.1016/j.jacc.2014.06.1207. Epub 2014 Oct 21.
5
Insurance type influences the use of drug-eluting stents.保险类型影响药物洗脱支架的使用。
JACC Cardiovasc Interv. 2010 Jul;3(7):773-9. doi: 10.1016/j.jcin.2010.04.011.
6
Drug-eluting or bare-metal stenting in patients with diabetes mellitus: results from the Massachusetts Data Analysis Center Registry.糖尿病患者的药物洗脱支架或裸金属支架置入术:来自马萨诸塞州数据分析中心注册研究的结果
Circulation. 2008 Nov 25;118(22):2277-85, 7p following 2285. doi: 10.1161/CIRCULATIONAHA.108.820159. Epub 2008 Nov 10.
7
Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients.裸金属支架、第一代药物洗脱支架和第二代药物洗脱支架的支架血栓形成风险:来自 18334 名患者的注册研究结果。
JACC Cardiovasc Interv. 2013 Dec;6(12):1267-74. doi: 10.1016/j.jcin.2013.06.015.
8
Gender disparity in the use of drug-eluting stents during percutaneous coronary intervention for acute myocardial infarction.急性心肌梗死经皮冠状动脉介入治疗中药物洗脱支架使用的性别差异。
Catheter Cardiovasc Interv. 2015 Aug;86(2):221-8. doi: 10.1002/ccd.25837. Epub 2015 Mar 19.
9
Impact of stent diameter and length on in-stent restenosis after DES vs BMS implantation in patients needing large coronary stents-A clinical and health-economic evaluation.在需要大型冠状动脉支架的患者中,药物洗脱支架(DES)与裸金属支架(BMS)植入后支架直径和长度对支架内再狭窄的影响——一项临床和卫生经济学评估
Cardiovasc Ther. 2017 Feb;35(1):19-25. doi: 10.1111/1755-5922.12229.
10
Disparity in drug-eluting stent utilization by insurance type.不同保险类型在药物洗脱支架使用上的差异。
Am Heart J. 2008 Dec;156(6):1133-40. doi: 10.1016/j.ahj.2008.07.012. Epub 2008 Oct 2.

引用本文的文献

1
Clinical Efficacy and Safety of Reduced-Dose Prasugrel After Percutaneous Coronary Intervention for Taiwanese Patients with Acute Coronary Syndromes.台湾急性冠状动脉综合征患者经皮冠状动脉介入治疗后使用低剂量普拉格雷的临床疗效与安全性
J Clin Med. 2024 Nov 27;13(23):7221. doi: 10.3390/jcm13237221.
2
Medical Practice Variation Among Primary Care Physicians: 1 Decade, 14 Health Services, and 3,238,498 Patient-Years.初级保健医生的医疗实践差异:10 年,14 个卫生服务和 3238498 患者年。
Ann Fam Med. 2021 Jan-Feb;19(1):30-37. doi: 10.1370/afm.2627.
3
Determinants of Medical Practice Variation Among Primary Care Physicians: Protocol for a Three Phase Study.

本文引用的文献

1
Socioeconomic inequalities in access to treatment for coronary heart disease: A systematic review.冠心病治疗可及性方面的社会经济不平等:一项系统评价。
Int J Cardiol. 2016 Sep 15;219:70-8. doi: 10.1016/j.ijcard.2016.05.066. Epub 2016 May 14.
2
Improved outcomes of elderly patients treated with drug-eluting versus bare metal stents in large coronary arteries: results from the BAsel Stent Kosten-Effektivitäts Trial PROspective Validation Examination randomized trial.在大型冠状动脉中,接受药物洗脱支架与裸金属支架治疗的老年患者预后改善:巴塞尔支架成本效益试验前瞻性验证检查随机试验的结果
Am Heart J. 2015 Oct;170(4):787-795.e1. doi: 10.1016/j.ahj.2015.07.009. Epub 2015 Jul 17.
3
基层医疗医生医疗实践差异的决定因素:一项三阶段研究方案
JMIR Res Protoc. 2020 Oct 20;9(10):e18673. doi: 10.2196/18673.
4
Survival outcomes post percutaneous coronary intervention: Why the hype about stent type? Lessons from a healthcare system in India.经皮冠状动脉介入治疗后的生存结果:支架类型的炒作有何意义?来自印度医疗体系的教训。
PLoS One. 2018 May 24;13(5):e0196830. doi: 10.1371/journal.pone.0196830. eCollection 2018.
Comparison among patients≥75 years having percutaneous coronary angioplasty using drug-eluting stents versus bare metal stents.
Am J Cardiol. 2015 May 1;115(9):1179-84. doi: 10.1016/j.amjcard.2015.01.557. Epub 2015 Feb 16.
4
Socioeconomic inequalities in quality of care and outcomes among patients with acute coronary syndrome in the modern era of drug eluting stents.药物洗脱支架现代时代急性冠状动脉综合征患者护理质量和治疗结果中的社会经济不平等
J Am Heart Assoc. 2014 Nov 14;3(6):e001029. doi: 10.1161/JAHA.114.001029.
5
The influence of age on clinical outcomes in patients treated with the resolute zotarolimus-eluting stent.
Catheter Cardiovasc Interv. 2016 Feb 1;87(2):253-61. doi: 10.1002/ccd.25334. Epub 2015 Nov 27.
6
Variation in use of dual-chamber implantable cardioverter-defibrillators: results from the national cardiovascular data registry.双腔植入式心脏复律除颤器使用情况的差异:来自国家心血管数据注册库的结果
Arch Intern Med. 2012 Apr 23;172(8):634-41; discussion 641. doi: 10.1001/archinternmed.2012.394.
7
Variations in the use of an innovative technology by payer: the case of drug-eluting stents.按支付方划分的创新技术使用情况变化:药物洗脱支架案例。
Med Care. 2012 Jan;50(1):1-9. doi: 10.1097/MLR.0b013e31822d5de9.
8
Regional variations in physicians' attitudes and recommendations surrounding implantable cardioverter-defibrillators.医生对植入式心脏除颤器的态度和建议的地区差异。
J Card Fail. 2011 Apr;17(4):318-24. doi: 10.1016/j.cardfail.2010.11.009. Epub 2011 Feb 22.
9
Social conditions as fundamental causes of health inequalities: theory, evidence, and policy implications.社会条件是健康不平等的根本原因:理论、证据和政策含义。
J Health Soc Behav. 2010;51 Suppl:S28-40. doi: 10.1177/0022146510383498.
10
Understanding racial-ethnic disparities in health: sociological contributions.理解健康中的种族-民族差异:社会学的贡献。
J Health Soc Behav. 2010;51 Suppl(Suppl):S15-27. doi: 10.1177/0022146510383838.